Prescription drug · BLA

Adalimumab (Adalimumab-aaty) NDC 72606-022

Kit · CELLTRION USA, Inc.

NDC codes

FDA NDC Directory
Product NDC (as listed)72606-022Labeler and product segments. Claims need a package NDC.
Product NDC at billing width72606-0022Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
72606-022-01726060022011 KIT in 1 CARTON (72606-022-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKETMarketed from Nov 30, 2023
72606-022-02726060022022 KIT in 1 CARTON (72606-022-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKETMarketed from Nov 30, 2023
72606-022-03726060022034 KIT in 1 CARTON (72606-022-03) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKETMarketed from Nov 30, 2023
72606-022-04726060022046 KIT in 1 CARTON (72606-022-04) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKETMarketed from Nov 30, 2023
72606-022-05726060022051 KIT in 1 CARTON (72606-022-05) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKETMarketed from Nov 30, 2023
72606-022-06726060022062 KIT in 1 CARTON (72606-022-06) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKETMarketed from Nov 30, 2023
72606-022-07726060022074 KIT in 1 CARTON (72606-022-07) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKETMarketed from Nov 30, 2023
72606-022-08726060022086 KIT in 1 CARTON (72606-022-08) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKETMarketed from Nov 30, 2023
72606-022-09726060022091 KIT in 1 CARTON (72606-022-09) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKETMarketed from Nov 30, 2023
72606-022-10726060022102 KIT in 1 CARTON (72606-022-10) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKETMarketed from Nov 30, 2023
72606-022-11726060022114 KIT in 1 CARTON (72606-022-11) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKETMarketed from Nov 30, 2023
72606-022-12726060022126 KIT in 1 CARTON (72606-022-12) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKETMarketed from Nov 30, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Adalimumab
Generic name (nonproprietary)
adalimumab-aaty
Dosage form
Kit
Labeler
CELLTRION USA, Inc.NDC labeler code 72606
Product type
Prescription drug
Marketing category
BLA — Biologics License ApplicationApplication BLA 761219
Marketing start
Listing expires
Identifiers
Product ID 72606-022_4ba7057b-2495-42ba-9c35-95d87449259cSPL ID 4ba7057b-2495-42ba-9c35-95d87449259cSPL set ID c44365e9-d470-4e35-978d-8565a9e3471eRxCUI 797544, 2639651, 2639659, 2668483, 2668485, 2668487, 2668489

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N472606002201 followed by a unit qualifier and the quantity

Package 72606-0022-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Adalimumab-aaty is a tumor necrosis factor (TNF) blocker indicated for: Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active r heumatoid arthritis . ( 1.1 ) Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. ( 1.2 ) Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active p soriatic arthritis . ( 1.3 ) Reducing signs and symptoms in adult patients with active ankylosing spondyli…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72606-022

What is NDC 72606-022?
72606-022 is the product NDC for Adalimumab (adalimumab-aaty) kit, listed with the FDA by CELLTRION USA, Inc.. It has 12 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Adalimumab (Adalimumab-aaty).
Who is the labeler?
CELLTRION USA, Inc., NDC labeler code 72606. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Adalimumab?
9 other product NDCs are listed under this name. See all Adalimumab NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Adalimumab NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
Adalimumabadalimumab-adazAdalimumab 10 mg/.1mLInjection, SolutionSubcutaneousSandoz Inc61314-39161314-0391-64
Adalimumabadalimumab-adazAdalimumab 80 mg/.8mLInjection, SolutionSubcutaneousSandoz Inc61314-32561314-0325-20
Adalimumabadalimumab-adazAdalimumab 20 mg/.2mLInjection, SolutionSubcutaneousSandoz Inc61314-33261314-0332-64
Adalimumabadalimumab-fkjp—KitBiocon Biologics Inc83257-02083257-0020-42
Adalimumabadalimumab-fkjp—KitBiocon Biologics Inc83257-02183257-0021-42
Adalimumabadalimumab-fkjp—KitBiocon Biologics Inc83257-02283257-0022-32
Adalimumabadalimumab-aaty—KitCELLTRION USA, Inc.72606-04072606-0040-0172606-0040-0272606-0040-03+3 more
Adalimumabadalimumab-aaty—KitCELLTRION USA, Inc.72606-04172606-0041-01
Adalimumabadalimumab-adazAdalimumab 40 mg/.4mLInjection, SolutionSubcutaneousSandoz Inc61314-32761314-0327-2061314-0327-64

Other NDCs under BLA 761219

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 761219
ProductStrengthForm · routeLabelerProduct NDC
Yuflymaadalimumab-aaty—KitCELLTRION USA, Inc.72606-023
Yuflymaadalimumab-aaty—KitCELLTRION USA, Inc.72606-030
Adalimumabadalimumab-aaty—KitCELLTRION USA, Inc.72606-040
Adalimumabadalimumab-aaty—KitCELLTRION USA, Inc.72606-041

Med-Code uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in
Adalimumab NDC 72606-022 | National Drug Code | Med-Code